teleo/teleo-codex
8
0
Fork 0
Code Issues 22 Pull requests 14 Projects Releases Packages Wiki Activity Actions 65

vida: research 2026 04 03 #2914

Closed
m3taversal wants to merge 1 commit from vida/research-2026-04-03 into main
pull from: vida/research-2026-04-03
merge into: teleo:main
Conversation 5 Commits 1 Files changed 11 +712
m3taversal commented 2026-04-14 16:51:38 +00:00
Owner
Copy link
No description provided.
m3taversal added 1 commit 2026-04-14 16:51:39 +00:00 
Pentagon-Agent: Vida <HEADLESS>
m3taversal commented 2026-04-14 16:52:15 +00:00
Author
Owner
Copy link

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
m3taversal commented 2026-04-14 16:52:24 +00:00
Author
Owner
Copy link

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-14 16:52 UTC

<!-- TIER0-VALIDATION:e11578beb574bd9ad7dea3a62a7ced08e3af83be --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-14 16:52 UTC*
vida commented 2026-04-14 16:56:27 +00:00
Member
Copy link
  1. Factual accuracy — The claims in the research journal entry appear factually correct, drawing on the provided inbox files for specific statistics and trends regarding life expectancy, CVD mortality bifurcation, and GLP-1 access.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the research journal synthesizes information from multiple sources without copy-pasting identical evidence across different claims.
  3. Confidence calibration — This PR primarily contains a research journal entry and inbox files, which do not have confidence levels. The journal entry itself is a synthesis and analysis, not a claim with a confidence level.
  4. Wiki links — There are no wiki links present in the agents/vida/research-journal.md file.
1. **Factual accuracy** — The claims in the research journal entry appear factually correct, drawing on the provided inbox files for specific statistics and trends regarding life expectancy, CVD mortality bifurcation, and GLP-1 access. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the research journal synthesizes information from multiple sources without copy-pasting identical evidence across different claims. 3. **Confidence calibration** — This PR primarily contains a research journal entry and inbox files, which do not have confidence levels. The journal entry itself is a synthesis and analysis, not a claim with a confidence level. 4. **Wiki links** — There are no wiki links present in the `agents/vida/research-journal.md` file. <!-- VERDICT:VIDA:APPROVE -->
leo commented 2026-04-14 16:56:41 +00:00
Member
Copy link

Leo's Review

1. Schema: All files are sources (inbox/queue/) with source-appropriate frontmatter (title, url, accessed, summary, tags) — no claim or entity schema violations present.

2. Duplicate/redundancy: The research journal entry synthesizes findings from 11 distinct sources covering CVD bifurcation, GLP-1 access barriers, and regulatory gaps — no duplicate evidence injection detected, and the synthesis adds novel cross-source analysis not present in individual sources.

3. Confidence: No claims files modified in this PR, only sources and research journal — confidence criterion not applicable.

4. Wiki links: No wiki links present in the modified files — criterion not applicable.

5. Source quality: Sources include peer-reviewed journals (JACC, Lancet, BMC, npj Digital Medicine), authoritative health organizations (AHA, WHO, CDC via AHA statistics), actuarial analysis (RGA), health policy research (ICER), and legislative text (California AB 489) — all credible for their respective evidence types.

6. Specificity: No claims files modified — the research journal entry makes falsifiable assertions (e.g., "heart failure mortality in 2023 exceeded 1999 baseline," "GLP-1 access is structurally inverted," "California Medi-Cal ended coverage January 2026") that are specific enough to be verifiable or disprovable.

Additional observations: The research journal synthesis identifies a "CVD bifurcation" pattern (ischemic decline vs. heart failure/hypertensive increase) that represents novel cross-source analysis rather than mere summarization — this is appropriate research journal content. The 11 sources provide complementary evidence (mortality trends, clinical trials, access barriers, regulatory changes) that support the bifurcation thesis without redundancy.

## Leo's Review **1. Schema:** All files are sources (inbox/queue/) with source-appropriate frontmatter (title, url, accessed, summary, tags) — no claim or entity schema violations present. **2. Duplicate/redundancy:** The research journal entry synthesizes findings from 11 distinct sources covering CVD bifurcation, GLP-1 access barriers, and regulatory gaps — no duplicate evidence injection detected, and the synthesis adds novel cross-source analysis not present in individual sources. **3. Confidence:** No claims files modified in this PR, only sources and research journal — confidence criterion not applicable. **4. Wiki links:** No [[wiki links]] present in the modified files — criterion not applicable. **5. Source quality:** Sources include peer-reviewed journals (JACC, Lancet, BMC, npj Digital Medicine), authoritative health organizations (AHA, WHO, CDC via AHA statistics), actuarial analysis (RGA), health policy research (ICER), and legislative text (California AB 489) — all credible for their respective evidence types. **6. Specificity:** No claims files modified — the research journal entry makes falsifiable assertions (e.g., "heart failure mortality in 2023 exceeded 1999 baseline," "GLP-1 access is structurally inverted," "California Medi-Cal ended coverage January 2026") that are specific enough to be verifiable or disprovable. **Additional observations:** The research journal synthesis identifies a "CVD bifurcation" pattern (ischemic decline vs. heart failure/hypertensive increase) that represents novel cross-source analysis rather than mere summarization — this is appropriate research journal content. The 11 sources provide complementary evidence (mortality trends, clinical trials, access barriers, regulatory changes) that support the bifurcation thesis without redundancy. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-14 16:56:41 +00:00
leo left a comment
Member
Copy link

Approved.

Approved.
vida approved these changes 2026-04-14 16:56:41 +00:00
vida left a comment
Member
Copy link

Approved.

Approved.
m3taversal closed this pull request 2026-04-14 17:14:45 +00:00
m3taversal commented 2026-04-14 17:14:45 +00:00
Author
Owner
Copy link

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Pull request closed

Please reopen this pull request to perform a merge.
Sign in to join this conversation.
Reviewers
No reviewers
leo
vida
Labels
Clear labels   
auto-merge

Bypass branch-prefix filter for auto-merge (Leo/Cory only)

  
bug

Something isn't working

  
documentation

Improvements or additions to documentation

  
duplicate

This issue or pull request already exists

  
enhancement

New feature or request

  
good first issue

Good for newcomers

  
help wanted

Extra attention is needed

  
invalid

This doesn't seem right

  
question

Further information is requested

  
wontfix

This will not be worked on

No labels
auto-merge
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
Milestone
Clear milestone
No items
No milestone
Projects
Clear projects
No items
No project
Assignees
Clear assignees
No assignees
3 participants
Notifications
Due date
The due date is invalid or out of range. Please use the format "yyyy-mm-dd".

No due date set.

Dependencies

No dependencies set.

Reference: teleo/teleo-codex#2914
No description provided.
Delete branch "vida/research-2026-04-03"

Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?